Add time:07/29/2019         Source:sciencedirect.com

BackgroundAlzheimer's disease (AD) biomarkers, such as cerebrospinal fluid (CSF) amyloid-β (1–42; Aβ42), can provide high diagnostic accuracy. Several immunoassays are available for Aβ42 quantitation, but standardisation across assays remains an issue. We compared the Elecsys® β-Amyloid (1–42) CSF assay with three assays and two liquid chromatography tandem mass spectrometry (LC-MS/MS) methods.

We also recommend Trading Suppliers and Manufacturers of BETA-AMYLOID (1-43) (cas 134500-80-4). Pls Click Website Link as below: cas 134500-80-4 suppliers